CING
Price
$4.10
Change
+$0.03 (+0.74%)
Updated
Dec 18, 04:59 PM (EDT)
ELVN
Price
$22.43
Change
-$1.96 (-8.04%)
Updated
Dec 18, 04:59 PM (EDT)
85 days until earnings call
Ad is loading...

CING vs ELVN

Header iconCING vs ELVN Comparison
Open Charts CING vs ELVNBanner chart's image
Cingulate
Price$4.10
Change+$0.03 (+0.74%)
Volume$129
CapitalizationN/A
Enliven Therapeutics
Price$22.43
Change-$1.96 (-8.04%)
Volume$9.26K
CapitalizationN/A
CING vs ELVN Comparison Chart
Loading...
CING
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CING vs. ELVN commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CING is a StrongBuy and ELVN is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (CING: $4.07 vs. ELVN: $24.39)
Brand notoriety: CING and ELVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CING: 46% vs. ELVN: 102%
Market capitalization -- CING: $13.07M vs. ELVN: $1.19B
CING [@Biotechnology] is valued at $13.07M. ELVN’s [@Biotechnology] market capitalization is $1.19B. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CING’s FA Score shows that 1 FA rating(s) are green whileELVN’s FA Score has 0 green FA rating(s).

  • CING’s FA Score: 1 green, 4 red.
  • ELVN’s FA Score: 0 green, 5 red.
According to our system of comparison, ELVN is a better buy in the long-term than CING.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CING’s TA Score shows that 4 TA indicator(s) are bullish while ELVN’s TA Score has 6 bullish TA indicator(s).

  • CING’s TA Score: 4 bullish, 4 bearish.
  • ELVN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ELVN is a better buy in the short-term than CING.

Price Growth

CING (@Biotechnology) experienced а -6.00% price change this week, while ELVN (@Biotechnology) price change was +2.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

CING is expected to report earnings on Mar 08, 2024.

ELVN is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELVN($1.19B) has a higher market cap than CING($13.1M). ELVN YTD gains are higher at: 76.228 vs. CING (-95.566). CING has higher annual earnings (EBITDA): -15.57M vs. ELVN (-100.07M). ELVN has more cash in the bank: 292M vs. CING (10M). ELVN has less debt than CING: ELVN (85K) vs CING (234K). CING (0) and ELVN (0) have equivalent revenues.
CINGELVNCING / ELVN
Capitalization13.1M1.19B1%
EBITDA-15.57M-100.07M16%
Gain YTD-95.56676.228-125%
P/E RatioN/AN/A-
Revenue00-
Total Cash10M292M3%
Total Debt234K85K275%
TECHNICAL ANALYSIS
Technical Analysis
CINGELVN
RSI
ODDS (%)
Bullish Trend 7 days ago
84%
Bullish Trend 2 days ago
65%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 10 days ago
82%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 9 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 3 days ago
76%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
CING
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTRK1.56-0.01
-0.64%
Ontrak Inc
EG355.06-2.71
-0.76%
Everest Group Ltd
TMCI7.45-0.13
-1.78%
Treace Medical Concepts
XYF8.22-0.17
-2.03%
X Financial
APAM45.77-1.61
-3.40%
Artisan Partners Asset Management

CING and

Correlation & Price change

A.I.dvisor tells us that CING and GOVX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CING and GOVX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CING
1D Price
Change %
CING100%
+0.99%
GOVX - CING
29%
Poorly correlated
-0.87%
BEIGF - CING
29%
Poorly correlated
N/A
ELVN - CING
29%
Poorly correlated
+3.48%
SLNO - CING
28%
Poorly correlated
-0.58%
SNBIF - CING
28%
Poorly correlated
N/A
More

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with OCEA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then OCEA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
+3.48%
OCEA - ELVN
48%
Loosely correlated
-2.34%
CRNX - ELVN
46%
Loosely correlated
+1.35%
BPMC - ELVN
39%
Loosely correlated
+1.14%
VYGR - ELVN
38%
Loosely correlated
-3.55%
ACLX - ELVN
38%
Loosely correlated
-1.67%
More